Neurology Minute

A Phase 3 Trial of Upadacitinib for Giant-Cell Arteritis

Informações:

Synopsis

Dr. Shuvro Roy and Dr. Daniel Blockmans discuss the efficacy and safety of upadacitinib as a treatment option for giant-cell arteritis.  Show reference:  https://www.nejm.org/doi/10.1056/NEJMoa2413449